{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:06:13Z","timestamp":1789545973553,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bonr.2026.101945","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:38:35Z","timestamp":1788190715000},"page":"101945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Orthopaedic diagnostic pitfalls in fibroblast growth factor 23-mediated hypophosphatemic rickets\/osteomalacia in fibrous dysplasia\/McCune-Albright syndrome: Two burosumab-treated cases"],"prefix":"10.1016","volume":"30","author":[{"given":"Tomoo","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Koda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bonr.2026.101945_bb0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bonr.2026.101945_bb0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous dysplasia\/McCune-Albright syndrome: a rare, mosaic disease of g\u03b1s activation","volume":"41","author":"Boyce","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bonr.2026.101945_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41413-026-00523-7","article-title":"A phase 2 trial of burosumab for treatment of fibroblast growth factor-23-mediated hypophosphatemia in children and adults with fibrous dysplasia","volume":"14","author":"de Jong","year":"2026","journal-title":"Bone Res."},{"issue":"5","key":"10.1016\/j.bonr.2026.101945_bb0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00774-015-0698-7","article-title":"Pathogenesis and diagnostic criteria for rickets and osteomalacia--proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society","volume":"33","author":"Fukumoto","year":"2015","journal-title":"J. Bone Miner. Metab."},{"issue":"5","key":"10.1016\/j.bonr.2026.101945_bb0025","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1210\/clinem\/dgad671","article-title":"Serum phosphorus as a driver of skeletal morbidity in fibrous dysplasia","volume":"109","author":"Gun","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bonr.2026.101945_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1297\/cpe.25.71","article-title":"Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey","volume":"25","author":"Isojima","year":"2016","journal-title":"Clin. Pediatr. Endocrinol."},{"issue":"1","key":"10.1016\/j.bonr.2026.101945_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13023-019-1102-9","article-title":"Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium","volume":"14","author":"Javaid","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.bonr.2026.101945_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1194\/jlr.R031534","article-title":"Cytochrome P450-mediated metabolism of vitamin D","volume":"55","author":"Jones","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.bonr.2026.101945_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/ped.70260","article-title":"Clinical features of low serum alkaline phosphatase levels in children: a retrospective study","volume":"67","author":"Kurihara","year":"2025","journal-title":"Pediatr. Int."},{"issue":"4","key":"10.1016\/j.bonr.2026.101945_bb0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1359\/JBMR.0301262","article-title":"Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome","volume":"19","author":"Leet","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bonr.2026.101945_bb0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1210\/clinem\/dgad744","article-title":"Incidence and prevalence of fibrous dysplasia\/McCune-Albright syndrome: a Nationwide registry-based study in Denmark","volume":"109","author":"Meier","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101945_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002427","article-title":"Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice","volume":"14","author":"Murali","year":"2016","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.bonr.2026.101945_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1507\/endocrj.EJ16-0548","volume":"64","author":"Okazaki","year":"2017","journal-title":"Endocr. J."},{"issue":"3","key":"10.1016\/j.bonr.2026.101945_bb0070","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/clinem\/dgad597","article-title":"LMS-based pediatric reference values for parameters of phosphate homeostasis in the HARP cohort","volume":"109","author":"Pott","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bonr.2026.101945_bb0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bonr.2026.101945_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1297\/cpe.2025-0063","article-title":"Burosumab treatment for FGF23-related hypophosphatemia in a two-year-old girl with McCune-Albright syndrome","volume":"35","author":"Saito","year":"2026","journal-title":"Clin. Pediatr. Endocrinol."},{"issue":"5","key":"10.1016\/j.bonr.2026.101945_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf042","article-title":"Burosumab treatment of a child with McCune-Albright syndrome\/polyostotic fibrous dysplasia: challenges and benefits","volume":"9","author":"Sakka","year":"2025","journal-title":"JBMR Plus"},{"issue":"6","key":"10.1016\/j.bonr.2026.101945_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000504802","article-title":"The clinical Spectrum of McCune-Albright syndrome and its management","volume":"92","author":"Spencer","year":"2019","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bonr.2026.101945_bb0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","article-title":"Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro","volume":"23","author":"Wang","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101945_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cca.2012.10.036","article-title":"Pediatric reference intervals for four serum bone markers using two automated immunoassays","volume":"415","author":"Wyness","year":"2013","journal-title":"Clin. Chim. Acta"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:39:32Z","timestamp":1789544372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187226000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"alternative-id":["S2352187226000495"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101945","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orthopaedic diagnostic pitfalls in fibroblast growth factor 23-mediated hypophosphatemic rickets\/osteomalacia in fibrous dysplasia\/McCune-Albright syndrome: Two burosumab-treated cases","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101945"}}